434 related articles for article (PubMed ID: 19634343)
1. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
2. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
Gannu R; Vishnu YV; Kishan V; Rao YM
Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
[TBL] [Abstract][Full Text] [Related]
3. Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization.
Madishetti SK; Palem CR; Gannu R; Thatipamula RP; Panakanti PK; Yamsani MR
Daru; 2010; 18(3):221-9. PubMed ID: 22615620
[TBL] [Abstract][Full Text] [Related]
4. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
6. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
7. Development of mucoadhesive patches for buccal administration of carvedilol.
Vishnu YV; Chandrasekhar K; Ramesh G; Rao YM
Curr Drug Deliv; 2007 Jan; 4(1):27-39. PubMed ID: 17269915
[TBL] [Abstract][Full Text] [Related]
8. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
Tirunagari M; Jangala VR; Khagga M; Gannu R
Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
[TBL] [Abstract][Full Text] [Related]
9. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.
Ubaidulla U; Reddy MV; Ruckmani K; Ahmad FJ; Khar RK
AAPS PharmSciTech; 2007 Jan; 8(1):2. PubMed ID: 17408218
[TBL] [Abstract][Full Text] [Related]
10. Matrix-type transdermal drug delivery system of trandolapril: in vitro and ex vivo characterization.
Tirunagari M; Rao Jangala V; Khagga M; Gannu R
PDA J Pharm Sci Technol; 2010; 64(1):44-53. PubMed ID: 21502003
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of carvedilol transdermal patches.
Tanwar YS; Chauhan CS; Sharma A
Acta Pharm; 2007 Jun; 57(2):151-9. PubMed ID: 17507312
[TBL] [Abstract][Full Text] [Related]
12. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.
Thimmasetty J; Pandey G; Babu P
Pak J Pharm Sci; 2008 Jul; 21(3):241-8. PubMed ID: 18614419
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.
Dixit N; Kohli K; Baboota S
PDA J Pharm Sci Technol; 2008; 62(1):46-55. PubMed ID: 18402367
[TBL] [Abstract][Full Text] [Related]
14. Formulation of Polymers-Based Methotrexate Patches and Investigation of the Effect of Various Penetration Enhancers: In Vitro, Ex Vivo and In Vivo Characterization.
Latif MS; Nawaz A; Rashid SA; Akhlaq M; Iqbal A; Khan MJ; Khan MS; Lim V; Alfatama M
Polymers (Basel); 2022 May; 14(11):. PubMed ID: 35683883
[TBL] [Abstract][Full Text] [Related]
15. Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil.
Al-Saidan SM; Krishnaiah YS; Chandrasekhar DV; Lalla JK; Rama B; Jayaram B; Bhaskar P
Skin Pharmacol Physiol; 2004; 17(6):310-20. PubMed ID: 15528962
[TBL] [Abstract][Full Text] [Related]
16. Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks.
Aktas E; Eroglu H; Kockan U; Oner L
Drug Dev Ind Pharm; 2013 Aug; 39(8):1207-16. PubMed ID: 22804226
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro evaluation of buccoadhesive carvedilol tablets.
Yamsani VV; Gannu R; Kolli C; Rao ME; Yamsani MR
Acta Pharm; 2007 Jun; 57(2):185-97. PubMed ID: 17507315
[TBL] [Abstract][Full Text] [Related]
18. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
[TBL] [Abstract][Full Text] [Related]
19. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization.
Mamatha T; Venkateswara Rao J; Mukkanti K; Ramesh G
Daru; 2010; 18(1):9-16. PubMed ID: 22615587
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations.
Mutalik S; Udupa N
J Pharm Sci; 2004 Jun; 93(6):1577-94. PubMed ID: 15124215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
